Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DR26FX3L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,547
Award facts
- Contract value 100% obligated
- $20,547.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $20,547.13 on November 5, 2025, for the supply of CIMZIA 2x200 mg/ml syringe kits, with a completion date of November 6, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and has demonstrated capability to meet DLA requirements through open competition. The company's extensive portfolio with DLA includes delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. CIMZIA (certolizumab pegol) is a TNF inhibitor used in treating inflammatory conditions, and this delivery order fulfills a specific medical supply need within the broader pharmaceutical support mission of DLA Troop Support.
Quick answers
Who was awarded contract SPE2DR26FX3L5?
SPE2DR26FX3L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FX3L5 worth?
The government has obligated $20,547 on SPE2DR26FX3L5.
Is contract SPE2DR26FX3L5 an order under another contract?
Yes. SPE2DR26FX3L5 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3L5 competed?
The extent of competition for SPE2DR26FX3L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award